Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision

Recruiting N/A Interventional Study
Rectal Neuroendocrine Neoplasm
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
30 (estimated)
Sponsor
National Cancer Center, China · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to investigate the metastatic status of lateral pelvic lymph nodes in rectal neuroendocrine neoplasms (rNENs) undergoing laparoscopic total mesenteric excision (TME). The hypothesis is that the rate of lateral lymph node metastasis is underestimated in rNENs undergoing TME, necessitating concurrent lateral Pelvic lymph node dissection.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Biopsy proven rectal neuroendocrine neoplasm (neuroendocrine tumor and carcinoma); 2. Meets any one of the following conditions: * Preoperative imaging examinations reveal that the maximum diameter of the tumor is greater than 2cm. * Preoperative imaging examinations r…
Contacts

Yueyang Zhang, M.D.

+8613552910035

yyzhang0129@163.com

CONTACT

Zheng Xu, M.D.

+8613141127297

1206164395@qq.com

CONTACT